$FENC has a nice short signal, the stock had a spectacular rally since it bottomed in early 2022, but could be reaching the end of the road here after drastically outperforming the market until now. Their drug received FDA approval in Sep 2022, commercial availability in the US in Oct 2022, but despite this, the latest report showed an increase in net loss YoY...
0.786 can be seen as a previous point of resistance
now that price has moved higher than this level, it will be seen as a point of support for the breakdown of the rising wedge , a pattern that is commonly bearish (as you can see on the chart)
Pharmaceutical companies are possibly hot right now, due to the emergence of the new COVID variant.
Buy the Dip.
I like the MACD cross and the close above the 61.8% Fibonacci level after testing it twice before. Also we should see a "golden cross" as the 50SMA crosses the 200MA in the next week or so. This of course would be very bullish.
1st target 9.41
2nd target 10.18
I found this because there's a substantial upside breakout pre-market on FENC today. I think that H & S formations are reversal signals that are supposed to happen only at major tops and bottoms but this looks a lot like an upside-down one... is it just a fluke caused by this morning's press release or is there a reference/explanation to this as a known phenomenon?
